Skip to main content
. 2020 Feb 7;2(1):vdaa012. doi: 10.1093/noajnl/vdaa012

Table 1.

Number of Pediatric CNS Tumors by Major Histology Grouping and Age Group at Diagnosis During the Period 2001–2015 in Canada

Histology Age at Diagnosis
0–14 years 0–4 years 5–9 years 10–14 years
Mean age (95% CI) n IR n IR n IR n IR
Low-grade glioma 6.93 (6.69–7.17) 1203 1.41 402 1.48 412 1.46 389 1.29
High-grade glioma 6.36 (6.07–6.65) 736 0.86 278 1.02 265 0.94 193 0.64
Embryonal tumors 5.46 (5.15–5.77) 619 0.72 292 1.07 213 0.76 114 0.38
 Medulloblastoma 6.25 (5.90–6.60) 425 0.50 158 0.58 177 0.63 90 0.30
 PNET 5.38 (4.59–6.17) 114 0.13 61 0.22 29 0.10 24 0.08
 ATRT 1.39 (0.98–1.80) 80 0.09 73 0.27 7 0.03 0 0.00
Ependymoma malignant 4.70 (4.18–5.23) 247 0.29 152 0.56 48 0.17 47 0.16
Other tumors 6.04 (5.45–6.64) 245 0.25 118 0.38 50 0.15 77 0.23
Craniopharyngioma 8.36 (7.76–8.97) 143 0.17 23 0.08 64 0.23 56 0.19
Malignant germ cell 9.73 (9.02–10.45) 113 0.13 13 0.05 28 0.10 72 0.24
Total 6.49 (6.31–6.60) 3306 3.80 1278 4.65 1080 3.79 948 3.11